UC Davis Comprehensive Cancer Center

Regina F. Gandour-Edwards, M.D. View profile as PDF

Regina F. Gandour-Edwards

Clinical/Research Interests

Regina Gandour-Edwards' expertise is in general surgical pathology with an emphasis on urologic cancers and head/neck cancers. She is leader of the Cancer Center Biorepository and has recently published studies relative to patient consenting issues and specimen quality in breast cancer. She has a joint appointment in Urology and has several years of collaboration with the prostate cancer program involving mechanisms of prostate cancer initiation and progression.

Title:

Professor

Specialty:

Pathology and Laboratory Medicine, Cancer

Center/Program Affiliation:

Education:

UC Davis School of Medicine
Sacramento, California
M.D. 1985

Georgetown University
Washington, District of Columbia
B.S. 1969

Residency:

University of California, Davis Medical Center
Sacramento, California
1985-90
Pathology

Board Certifications:

American Board of Pathology, Anatomic and Clinical Pathology, 1990

Professional Memberships:

College of American Pathologists
International Society for Biological and Environmental Repositories
International Society of Urologic Pathology
United States and Canadian Academy of Pathology

Select Recent Publications:

Bekele W, Gerscovich EO, Naderi S, Bishop J, Gandour-Edwards RF, McGahan JP. Sonography of an epidermoid inclusion cyst of the thyroid gland. J Ultrasound Med. 2012 Jan;31(1):128-9.

Chew HK, Somlo G, Mack PC, Gitlitz B, Gandour-Edwards R, Christensen S, Linden H, Solis LJ, Yang X, Davies AM. Phase I study of continuous and intermittent schedules of lapatinib in combination with vinorelbine in solid tumors. Ann Oncol. 2012 Apr;23(4):1023-9. Epub 2011 Jul 21.

Vinall RL, Mahaffey CM, Davis RR, Luo Z, Gandour-Edwards R, Ghosh PM, Tepper CG, de Vere White RW. Dual blockade of PKA and NF-?B inhibits H2 relaxin-mediated castrate-resistant growth of prostate cancer sublines and induces apoptosis. Horm Cancer. 2011 Aug;2(4):224-38.

Gerscovich EO, Naderi S, Gandour-Edwards RF. Serous papillary carcinoma of the tunica vaginalis testis. J Ultrasound Med. 2011 Mar;30(3):418-20.

Li B, Bobinski M, Gandour-Edwards R, Farwell DG, Chen AM. Overstaging of cartilage invasion by multidetector CT scan for laryngeal cancer and its potential effect on the use of organ preservation with chemoradiation. Br J Radiol. 2011 Jan;84(997):64-9. Epub 2010 Sep 21.

Bailey TL, Fung MA, Gandour-Edwards R, Ellis WG, Schrot RJ. Clinical emergence of neurometastatic merkel cell carcinoma: a surgical case series and literature review. J Neurooncol. 2011 Mar;102(1):147-55. Epub 2010 Jul 29.

Van Veldhuizen PJ, Hussey M, Lara PN Jr, Mack PC, Gandour-Edwards R, Clark JI, Lange MK, Crawford DE. A Phase" Study of Gemcitabine and Capecitabine in Patients with Advanced Renal Cell Cancer: Southwest Oncology Group Study S0312. Am J Clin Oncol. 2009 May 29. [Epub ahead of print] (PMID: 19487915)

Kim RH, Coates JM, Bowles TL, McNerney G, Sutcliffe J, Jung JU, Gandour-Edwards B., Chuang F, Bold RJ, Kung HJ. Arginine deaminase as a novel therapy for prostate cancer induces autophagy and caspase independent apoptosis. Cancer Research 69:700-708. 2009 (PMID: 19147587)

Gandour-Edwards R, Taylor S, Beckett LA. Tumor grade predicts tumor proportion in fresh frozen tissue samples for breast cancer research. Cell Preservation Technology 6:1-4. 2008

Shi XB, Xue L, Zou JX, Gandour-Edwards R, Chen H, deVere White RW. Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen independent growth of prostate cancer cells. The Prostate 68:1816-1826. 2008 (PMID: 18780293)